Skip to main content

LEPRE1 Antibody (OTI1H3) - Azide and BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72134

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-72134
Conjugate
Catalog #

Key Product Details

Species Reactivity

Human

Applications

CyTOF-ready, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # OTI1H3

Format

Azide and BSA Free

Concentration

LYOPH mg/ml

Product Specifications

Immunogen

Full length human recombinant protein of human LEPRE1(NP_071751) produced in HEK293T cell.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Theoretical MW

83.2 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Scientific Data Images for LEPRE1 Antibody (OTI1H3) - Azide and BSA Free

Western Blot: LEPRE1 Antibody (OTI1H3)Azide and BSA Free [NBP2-72134]

Western Blot: LEPRE1 Antibody (OTI1H3)Azide and BSA Free [NBP2-72134]

Western Blot: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LEPRE1.
Immunohistochemistry: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134]

Immunohistochemistry: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134]

Immunohistochemistry: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134] - Analysis of Human prostate tissue.
Flow Cytometry: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134]

Flow Cytometry: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134]

Flow Cytometry: LEPRE1 Antibody (OTI1H3) - Azide and BSA Free [NBP2-72134] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostaining by LEPRE1 antibody.

Applications for LEPRE1 Antibody (OTI1H3) - Azide and BSA Free

Application
Recommended Usage

Flow Cytometry

1:100

Immunohistochemistry

1:150

Western Blot

1:2000
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Reconstitution

we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process.

Formulation

Lyophilized from PBS (pH 7.3) with 8% Trehalose

Format

Azide and BSA Free

Preservative

No Preservative

Concentration

LYOPH mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: LEPRE1

LEPRE1 encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.

Alternate Names

EC 1.14.11.7, GROS1OI8, Growth suppressor 1, leprecan, Leprecan-1, Leucine- and proline-enriched proteoglycan 1, leucine proline-enriched proteoglycan (leprecan) 1, MGC117314, P3H1LEPRECAN, prolyl 3-hydroxylase 1

Gene Symbol

P3H1

Additional LEPRE1 Products

Product Documents for LEPRE1 Antibody (OTI1H3) - Azide and BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for LEPRE1 Antibody (OTI1H3) - Azide and BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...